Screening panels for monoclonal gammopathies: time to change

Item

http://www.wikidata.org/entity/Q42098619

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Screening panels for monoclonal gammopathies: time to change

@en

Screening panels for monoclonal gammopathies: time to change

@nl

type

Item

label

Screening panels for monoclonal gammopathies: time to change

@en

Screening panels for monoclonal gammopathies: time to change

@nl

prefLabel

Screening panels for monoclonal gammopathies: time to change

@en

Screening panels for monoclonal gammopathies: time to change

@nl

P1476

Screening panels for monoclonal gammopathies: time to change

@en

P2093

Jerry A Katzmann

http://www.w3.org/2001/XMLSchema#string

P2860

Appraisal of immunoglobulin free light chain as a marker of response

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

Immunoglobulin free light chains and solitary plasmacytoma of bone

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains

Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma.

P304

105-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19841692

http://www.w3.org/2001/XMLSchema#string

P932

2754998

http://www.w3.org/2001/XMLSchema#string